AKT1 and non-small cell lung carcinoma: In addition, we investigated the effect of Akt inhibitor on chemotherapy sensitivity of NSCLC cells, and the results showed that the addition of the Akt inhibitor A-44365 enhanced chemotherapy sensitivity and cisplatin-induced apoptosis in H1299 and HCC827 cells (Supplementary Fig. S1).